BSE · JOHNPHARMA
JOHNSON PHARMACARE LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,008
of 5,084 stocks
▼ 981W
Peak #3,910 · 21 Sep 2026
JOHNSON PHARMACARE LIMITED, a microcap Financial Services business, has a subdued return on equity and has a widely-held ownership base, with promoters at just 0%.
Market Cap
23.10 Cr
P/E Ratio
—
P/B Ratio
42.00
ROE
-12,806.50%
ROCE
-254.03%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | Rs 0 | Rs 0 | Rs 0 | Rs 0 |
| Net Profit | -1.10 Cr | -55.61 Cr | -6.40 L | -Rs 34,000 |
| EPS | 0.02 | -1.01 | 0.00 | 0.00 |
| Operating Profit | -4.14 L | -42.70 Cr | -2.39 L | -Rs 34,000 |
Shareholding pattern
Promoter
0.00%
Public
100.00%
PUBLIC BREAKDOWN
Individuals
86.52%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 07 Apr 2022 | Bonus | Bonus issue 1:10 |
| 05 Jan 2022 | Split | Stock Split From Rs.10/- to Rs.1/- |
| 06 Sep 2006 | Other | General |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.